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Abstract: The L-phenylalanine methyl ester derivative of dexamethasone-
derived cortienic acid (DF) was synthesized and its crystal structure charac-
terized by the X-ray diffraction method. The crystal system is orthorhombic 
with space group P212121 and cell constants a = 8.2969(3) Å, b = 18.9358(8) 
Å, c = 20.0904(6) Å, V = 3156.4(2) Å3 and Z = 4. Ring A of the steroid nucleus 
and phenyl ring in the 17β-side chain are almost planar. Rings B and C have a 
slightly distorted chair conformation, whereas ring D has an envelope con-
formation. The packing of DF is characterized by a network of intermolecular 
hydrogen bonds involving the O4 atom from one side of the steroid nucleus 
and O1 and F1 atoms from the other side as hydrogen bond acceptors. Apart 
from the intermolecular hydrogen bonds in the crystal packing, there are also 
numerous intramolecular hydrogen bonds of the N–H…O, C–H…O and 
C–H…F type. The local anti-inflammatory activity of DF was evaluated using 
the croton oil-induced ear oedema test. This derivative achieved maximal 
inhibition of ear oedema at significantly lower concentration in comparison 
with dexamethasone.  
Keywords: 17β-carboxamide steroids; X-ray diffraction; biological activity; ear 
oedema test. 
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INTRODUCTION 
Soft glucocorticoids are compounds synthesized using the retrometabolic 
approach and usually administered locally near the site of action. After local 
administration, these derivatives are easily biotransformed to non-toxic and inact-
ive metabolites, resulting in fewer side effects than traditional glucocorticoids. 
The first (loteprednol etabonate) and second (etiprednol dicloacetate) generations 
of soft glucocorticoids are derived from cortienic acid (an inactive glucocorticoid 
metabolite).1–3 Generally, other derivatives of glucocorticoids that are easily 
metabolized after local administration to non-toxic and inactive metabolites 
could also be denoted as soft (antedrug) glucocorticoids.4 Several groups of  
7β-carboxamide steroids were synthesized and tested for glucocorticoid activity. 
Some of these compounds showed significant glucocorticoid activity (inhibition 
of phytohaemagglutinin-induced blastogenesis of lymphocytes).5–7 However, 
their metabolic properties and toxicity have not been tested so far. 
A novel class of 17β-carboxamide derivatives of glucocorticoids was rec-
ently presented. These derivatives are amides of cortienic acids obtained from 
hydrocortisone, prednisolone, methylprednisolone, dexamethasone and beta-
methasone with amino acids. Molecular docking calculations indicate that intro-
duction of an amino acid moiety in the 17β side chain enables favourable orient-
ation in the glucocorticoid receptor (GR) and key binding interactions with the 
amino acids from the GR.8 Their permeability and retention in human skin were 
predicted by use of in vitro tests – parallel artificial membrane permeability assay 
(PAMPA) and biopartitioning micellar chromatography.9,10 According to these 
results, L-phenylalanine methyl ester derivatives should have significant local 
anti-inflammatory activity and a better skin retention/permeability ratio in com-
parison with corresponding parent glucocorticoids. 
The aim of this study was to synthesize the L-phenylalanine methyl ester 
derivative of dexamethasone-derived cortienic acid (DF), perform crystallogra-
phic analysis of its structure and test the local anti-inflammatory activity of this 
derivative. 
EXPERIMENTAL 
Materials and methods 
Dexamethasone was purchased from Tokyo Chemical Industry (Tokyo, Japan), whereas 
N-hydroxybenzotriazole (HOBt), N,N′-dicyclohexylcarbodiimide (DCC), croton oil, aceto-
nitrile, N,N-dimethylformamide (DMF) and silica gel for preparative thin-layer chromato-
graphy were purchased from Sigma–Aldrich (Steinheim, Germany). Triethylamine (TEA) and 
L-phenylalanine methyl ester hydrochloride were purchased from Acros Organics (Geel, Bel-
gium), chloroform and methanol from JT Baker (Loughborough, UK) and acetone from Zorka 
(Šabac, Serbia). Silica gel for column chromatography was purchased from Merck (Darm-
stadt, Germany). 
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Apparatus  
The melting point was determined using a Boetius PHMK 05 apparatus (Radebeul, 
Germany). The UV spectrum was recorded on an Evolution 300 spectrophotometer (Thermo 
Scientific, UK), whereas the IR spectrum was recorded using a Nicolet iS10 ATR-FTIR 
spectrophotometer (Thermo Scientific, Madison, WI, USA). The 1H- and 13C-NMR spectra 
were acquired on a Bruker Avance III 400 NMR spectrometer (Bruker Biospin GmbH, Rhein-
stetten, Germany), operating at 400 MHz for protons and 100 MHz for carbons. The accurate 
mass was determined using an Agilent 6210 time-of-flight mass spectrometer (Agilent Tech-
nologies, Palo Alto, CA, USA). The crystallographic data were collected on an Oxford Dif-
fraction Gemini S diffractometer. 
Synthesis  
The precursor (dexamethasone-derived cortienic acid, CD) was synthesized by periodic 
acid oxidation of dexamethasone, following a reported method.9  
DF was synthesized from CD and L-phenylalanine methyl ester hydrochloride by use of 
DCC, HOBt and TEA according to a reported procedure,8 which was a modification of a 
previously published method.11 CD (53 mg, 0.14 mmol, 1 eq) was dissolved in DMF (2 mL) 
and the solution was cooled to 0 °C. Subsequently, DCC (58 mg, 0.28 mmol, 2 eq) and HOBt 
(28 mg, 0.21 mmol, 1.5 eq) were added. The mixture was stirred at 0 °C for 1 h and thereafter 
maintained at a temperature not exceeding 8 °C for 15 h. L-Phenylalanine methyl ester hydro-
chloride (30 mg, 0.14 mmol, 1 eq) was dissolved in DMF (1 mL), TEA was added (39 μL, 
2 eq) and the mixture was cooled to 0 °C. Finally, the mixture of CD, DCC and HOBt was 
filtered and added dropwise. This reaction mixture was stirred at 0 °C for 1 h and maintained 
at a temperature not exceeding 8 °C for 15 h. The reaction mixture was filtered and evapor-
ated to dryness under reduced pressure. Column chromatography was employed for the initial 
purification of the reaction mixture, whereas the final purification was realised by preparative 
thin-layer chromatography. Mobile phase used for column chromatography purification was 
chloroform/methanol 99:1 (V/V), whereas the mobile phase used for the purification by pre-
parative thin-layer chromatography was chloroform/methanol 95:5 (V/V). The purified com-
pound was recrystallized from water/acetonitrile 50:50 (V/V). Yield: 83.5 %. 
X-Ray crystallography 
Details of crystal data, data collection and structure refinement are summarized in Table 
S-I of the Supplementary material to this paper. 
The structure was solved by the direct method using the program SHELXS-9712 and 
refined by SHELXL-97.13 The H atoms bonded to the N and O atoms were located from 
difference Fourier maps and the H atoms bonded to C atoms were placed at the geometrically 
calculated positions and refined using a riding model. C–H distances were fixed at 0.93 Å for 
aromatic C atoms, 0.97 Å for secondary C–H2 groups, 0.98 Å for tertiary C–H groups and 
0.96 Å for methyl C–H3 groups. Their Uiso(H) values are equal to 1.2Ueq of the corresponding 
C atom, except for the methyl groups where the Uiso(H) values were set to 1.5Ueq(C). In the 
absence of significant anomalous scattering, the absolute configuration could not be reliably 
determined and any reference to the Flack parameter14 was removed. In the phenyl ring, atoms 
C27, C28 and C29 show slightly elongated atomic displacement ellipsoids. Attempts to model 
disorder for the rings, even by employing extensive restraints, proved fruitless. Examination 
of the refined structure using PLATON15 revealed a total void volume of 280 Å3 distributed 
over two sites (–0.060, 0.250, 0.500) and (0.031, 0.750, 0.000). 
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Local anti-inflammatory activity assay 
The local anti-inflammatory activities of DF and dexamethasone were evaluated using 
the croton oil-induced ear oedema test,16-19 following the procedure described elsewhere.8 The 
experimental procedure was in accordance with the institutional guidelines for care and use of 
animals in research No 03/10-2013 (Ethics Committee in research of the Military Medical 
Academy, Belgrade, Serbia). Croton oil solution (35 µg mL-1), five solutions of DF (1.15, 
2.29, 4.58, 9.17 and 13.75 µM) and five solutions of dexamethasone (9.17, 13.75, 27.50, 
36.70 and 45.80 µM) were prepared in acetone. Eleven groups of experimental animals were 
formed – a control group and ten test groups (five groups for DF and five groups for dexa-
methasone, each containing five rats).  
RESULTS AND DISCUSSION 
Synthesis and physicochemical characterization  
DF was previously synthesized using a single-step procedure, which utilizes 
1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide (EDC), HOBt and TEA.9 In 
this paper, an alternative two-step synthesis of DF is presented (Scheme 1). By 
use of the two-step procedure, DF was synthesized in good yield (83.5 %), which 
is significantly higher in comparison with that obtained using the single-step syn-
thesis (52.1 %). 
 
Scheme 1. Synthesis of DF. 
DF was characterized by determining the melting point as well as by use of 
spectroscopy techniques (UV, IR, NMR, MS/MS and MS-TOF spectroscopy). 
The physical, analytical and spectral data for the title compound are given in the 
Supplementary material to this paper. 
Crystal structure 
DF crystallizes in the space group P212121. Its molecular structure with the 
atom-labelling scheme is shown in Fig. 1. Selected bond lengths and bond angles 
are listed in Table S-II of the Supplementary material to this paper. 
There are four fused rings, one five-membered (D) and three six-membered 
(A, B and C) rings. The five-membered ring D has an envelope conformation, 
with atom C13 at the flap position displaced by 0.757(2) Å from the best plane of 
the other four C atoms of the D ring (Q(2) = 0.5038(17) Å, φ(2) = 177.6(2)°). 
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The cyclohexane rings B and C have a slightly distorted chair conformation. The 
key puckering parameter20 for a chair conformation should be θ = 0° for an ideal 
chair. The values of θ are 10.16(18) and 9.26(18)° for rings B and C, respect-
ively. Other puckering parameters for ring B are Q = 0.5607(18) Å and φ = 
= 283.6(10)°, whereas for ring C, they are Q = 0.5311(17) Å and φ = 271.9(11)°. 
Rings A (C1–C2–C3–C4–C5–C10) and E (C24–C25–C26–C27–C28–C29) are 
almost planar with an average atom displacement of 0.015 Å for C24–C25–C26–
–C27–C28–C29 and 0.010 Å for C1–C2–C3–C4–C5–C10 from the plane defined 
by all atoms of the cyclohexane ring. 
Fig. 1. Molecular structure of 
DF showing the atom-labelling 
scheme. Displacement ellipsoids 
are drawn at the 30 % prob-
ability level. The H atoms are 
shown as small circles of arbit-
rary radii. 
The bonds C10–C20 and C9–F1 adopt the axial position at 2.95(10) and 
8.89(9)°, respectively, with respect to ring B of the steroid nucleus, whereas bond 
C16–C19 occupies a bisectional position at 56.1(1)° with respect to ring D. 
Bonds C13–C18 and C11–O2 adopt axial positions at 5.43(9) and 15.50(10)°, 
respectively, with respect to the ring C of the steroid nucleus.  
The length of the steroid nucleus C3…C16 is 8.586 Å and the dihedral angle 
between the mean planes of the steroid nucleus and the phenyl moiety (ring E) is 
78.73(12)°.  
The packing of DF is characterized by a network of hydrogen bonds invol-
ving the O4 atom from one side of the steroid nucleus and the O1 and F1 atoms 
from the other side as hydrogen bond acceptors. In the crystallographic b dir-
ection, chain growth is ensured by means of the O3–H…O1 and C29–H…F1 
interactions, forming a zigzag pattern (Fig. 2a and Table S-III of the 
Supplementary material). Similar zigzag pattern is formed down the crystallo-
graphic a-axis by O2–H…O4 hydrogen bonds (Fig. 2b and Table S-III). Besides 
the intermolecular hydrogen bonds in the crystal packing, there are numerous 
intramolecular hydrogen bonds of the N–H…O, C–H…O and C–H…F type 
(Table S-III). 
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Fig. 2. The crystal packing of DF 
viewed down: a) [100] showing 
the O3–H3O…O1 and C29– 
–H29…F1 hydrogen bonds, and 
b) [010] showing the O2– 
–H2O…O4 hydrogen bond. The 
hydrogen bonds are shown as 
dotted lines. For clarity H atoms 
not participating in the inter-
actions are omitted. 
Local anti-inflammatory activity  
Maximal inhibition of ear oedema caused by DF (29.54 %) was lower than 
the maximal inhibition caused by dexamethasone (55.54 %). However, DF could 
be applied at a lower concentration, because this derivative caused maximal inhi-
bition of ear oedema at a significantly lower concentration (4.58 µM) in com-
parison with dexamethasone (45.8 µM). Additionally, DF should have signific-
antly better skin retention/permeability ratio.9 The local anti-inflammatory pro-
file of DF is presented in Fig. 3. 
Fig. 3. Local anti-inflammatory 
profile of DF. 
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CONCLUSIONS 
The L-phenylalanine methyl ester derivative of dexamethasone-derived cor-
tienic acid (DF) was synthesized and structurally characterized. This derivative is 
a potential soft drug with fewer side effects and a better skin retention/perme-
ability ratio than dexamethasone. Its crystal structure was characterized by the 
X-ray diffraction method. Ring A of the steroid nucleus and the phenyl ring 
(17β-side chain) are almost planar, rings B and C have a slightly distorted chair 
conformation and ring D has an envelope conformation. Hydrogen bonds that 
influence crystal packing of this derivative were identified, i.e., O2–H…O4 
(crystallographic a direction), and O3–H…O1 and C29–H…F1 interactions 
(crystallographic b direction). The local anti-inflammatory activity of DF was 
evaluated by the croton oil-induced ear oedema test. This derivative possesses 
local anti-inflammatory activity with the maximal inhibition of ear oedema 
achieved at significantly lower concentration in comparison with dexamethasone.  
SUPPLEMENTARY MATERIAL 
The physical, spectral and crystal data for DF, selected bond lengths and angles, as well 
as hydrogen bond geometry of DF are available electronically from http://www.shd.org.rs/  
/JSCS/, or from the corresponding author on request.  
Crystallographic data for the structure reported in this paper have been deposited with 
the Cambridge Crystallographic Data Centre with deposition number CCDC-1034681. Copies 
of these can be obtained free of charge on written application to CCDC, 12 Union Road, 
Cambridge, CB2 1EZ, UK (fax: +44 1223 336033); on request by e-mail to 
deposit@ccdc.cam.ac.uk or by access to http://www.ccdc.cam.ac.uk. 
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СИНТЕЗА, КРИСТАЛНА СТРУКТУРА И ЛОКАЛНА АНТИИНФЛАМАТОРНА 
АКТИВНОСТ ДЕРИВАТА КОРТИЕНСКЕ КИСЕЛИНЕ ИЗ ДЕКСАМЕТАЗОНА И 
МЕТИЛ-ЕСТРА L-ФЕНИЛАЛАНИНА 
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Синтетисан је дериват кортиенске киселине из дексаметазона и метил-естра L-фе-
нилаланина (DF), а кристална структура овог једињења окарактерисана је методом 
дифракције X-зрака. Кристални систем je орторомбичан, са просторном групом P212121 
и константама a = 8,2969(3) Å3, b = 18,9358(8) Å3, c = 20,0904(6) Å3, V = 3156,4 Å3 и 
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Z = 4. Прстен А стероидне структуре и бензенов прстен у 17β-бочном низу су скоро пла-
нарни. Прстенови B и C су у благо искривљеној конформацији столице, док је прстен D у 
конформацији коверте. Кристална структура DF се карактерише мрежом интермолекул-
ских водоничних веза преко којих се атом О4 са једне стране стероидне структуре пове-
зује са атомима О1 и F1 (акцептори водоничне везе) са друге стране стероидне струк-
туре. Поред интермолекулских, присутне су и бројне интрамолекулске водоничне везе 
N–H…О, C–H…O и C–H…F типа. Локална антиинфламаторна активност DF је испитана 
применом теста инхибиције едема уха изазваног кротонским уљем. Овај дериват пос-
тиже максималну инхибицију едема уха при значајно нижој концентрацији у односу на 
дексаметазон. 
(Примљено 5. маја, ревидирано 6. јула, прихваћено 4. августа 2015) 
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